TAZ antibody (C-Term)
-
- Target See all TAZ Antibodies
- TAZ (Tafazzin (TAZ))
-
Binding Specificity
- C-Term
-
Reactivity
- Human
-
Host
- Goat
-
Clonality
- Polyclonal
-
Conjugate
- This TAZ antibody is un-conjugated
-
Application
- Western Blotting (WB), ELISA
- Purpose
- Tafazzin
- Sequence
- HLKTQAEQLH NH
- Specificity
- This antibody is expected to recognise isoforms 1to 4 (NP_000107.1, NP_851828.1, NP_851829.1, NP_851830.1, respectively).
- Cross-Reactivity
- Dog, Human, Mouse, Rat
- Purification
- Purified from goat serum by ammonium sulphate precipitation followed by antigen affinity chromatography using the immunizing peptide.
- Grade
- Verified
- Immunogen
- Peptide with sequence C-HLKTQAEQLHNH, from the C Terminus of the protein sequence according to NP_000107.1, NP_851828.1, NP_851829.1, NP_851830.1.
- Isotype
- IgG
- Top Product
- Discover our top product TAZ Primary Antibody
-
-
- Application Notes
-
Western Blot: Approx 28 kDa band observed in Human Heart lysates (calculated MW of 33.5 kDa according to NP_000107.1, 30.2 kDa according to NP_851828.1, 31.7 kDa according to NP_851829.1 and 28.5 according to NP_851830.1). Recommended concentration: 0.3-1.0
Peptide ELISA: antibody detection limit dilution 1:32000.
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Concentration
- 0.5 mg/mL
- Buffer
- Supplied at 0.5 mg/mL in Tris saline, 0.02 % sodium azide, pH 7.3 with 0.5 % bovine serum albumin.
- Preservative
- Sodium azide
- Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Handling Advice
- Minimize freezing and thawing.
- Storage
- -20 °C
- Storage Comment
- Aliquot and store at -20°C, with minimal freeze/thawing. A working aliquot may be refrigerated at 4°C for a few weeks and still remain viable.
-
- Target
- TAZ (Tafazzin (TAZ))
- Alternative Name
- TAZ (TAZ Products)
- Synonyms
- wu:fb39f12 antibody, zgc:91803 antibody, MGC54019 antibody, TAZ antibody, taz antibody, GB11956 antibody, Afu2g13960 antibody, BTHS antibody, CMD3A antibody, EFE antibody, EFE2 antibody, G4.5 antibody, LVNCX antibody, Taz1 antibody, 5031411C02Rik antibody, 9130012G04Rik antibody, AW107266 antibody, AW552613 antibody, tafazzin antibody, tafazzin L homeolog antibody, tafazzin homolog antibody, TAZ antibody, taz antibody, taz.L antibody, LOC550948 antibody, AFUA_2G13960 antibody, AOR_1_318014 antibody, Tsp_06712 antibody, Taz antibody
- Background
- TAZ, tafazzin (cardiomyopathy, dilated 3A (X-linked) endocardial fibroelastosis 2 Barth syndrome) , HGNC:11577, BTHS, CMD3A, EFE, EFE2, G4.5, XAP-2 , OTTHUMP00000061673, cardiomyopathy, dilated 3A (X-linked), tafazzin, XX-FW83563B9.3, FLJ27390, Taz1, LVNC
- Gene ID
- 6901
- NCBI Accession
- NP_000107, NP_851828, NP_851829, NP_851830
-